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•  Outpatient	 management	 was	 safe	 and	 effective	 for	
the	large	majority	of	patients.		
	
•  Outpatient	 management	 was	 associated	 with	 few	
complications	with	a	low	return	hospitalization	rate.	
	
•  Future	 studies	 are	 needed	 with	 a	 larger	 sample	 size	
and	a	more	diverse	population.		
	
BACKGROUND	&	OBJECTIVE	
METHODS	
RESULTS	
DISCHARGE	DATA	
	
•  118	(58%)	were	discharged	directly	home	
•  28	(19%)	were	discharged	following	treatment	in	the	
ED	clinical	decision	unit	
•  1	(0.7%)	left	against	medical	advice	
	
TREATMENT	DATA	
	
•  61	(40%)	received	a	NOAC	
•  33	(22%)	low	molecular	weight	heparin	
•  55	(36%)	low	molecular	weight	heparin	with	a	bridge	
to	warfarin	
Retrospective	 health	 records	 survey	 investigated	 a	 4-
year	 cohort	 of	 consecutive	 patients	 presenting	with	PE	
who	received	treatment	in	an	academic,	tertiary	ED	and	
were	discharged	to	home.		
	
151	patients	with	median	age	56	years	(20-94	years),	58%	
male	 and	 96%	 white,	 for	 which	 the	 following	 data	 was	
collected:	
•  sPESI	score	
•  Treatment	strategy	
•  NOAC	vs.	LMWH	vs.	Warfarin	with	bridge	
•  Return	visits	within	7	and	30	days 	 		
Pulmonary	 embolus	 (PE)	 is	 associated	 with	 significant	
utilization	of	health	care	resources	and	financial	burden	
	
Several	 additions	 that	 have	 allowed	us	 to	 look	 at	 safely	
treating	patients	with	PEs	as	outpatients:	
	
•  Simplified	Pulmonary	Embolism	Severity	Index	(sPESI)		
	 	 -Risk	 stratifies	 patients	 based	 on	 their	 age,	 vital	 	
			signs,	and	past	medical	history			
	 		
•  Novel	oral	anticoagulants	
	
Primary	 Objective:	 To	 describe	 the	 population,	
treatment	strategies,	short-term	complications	and	
outcomes	associated	with	outpatient	management	
of	PE	following	treatment	in	the	ED.	
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CONCLUSIONS	
Outpatient	Treatment	of	Pulmonary	Embolism:	A	Single-Center	Case	Series	
RESULTS	
SEVEN	DAY	COMPLICATIONS	DATA	
	
•  14	(9%)	returned	with	continued	PE	symptoms	
•  Chest	pain	
•  Shortness	of	breath		
	
THIRTY	DAY	COMPLICATIONS	DATA	
	
•  26	(17%)	returned	with	related	symptoms	
•  Chest	pain	
•  Shortness	of	breath	
•  Limb	pain/swelling	
	
ALL	COMPLICATIONS	(Combined	7	and	30	day)	
	
•  1	patient	(0.7%)	experienced	myocardial	infarction	
•  4	patients	(3%)	required	hospital	admission	
	
MEDICATION	SIDE	EFFECTS	(Within	30	days)	
	
•  6	(4%)	returned	with	medication	side	effects	
•  Hemoptysis	
•  Hematuria	
•  Vaginal	bleeding	
•  None	required	hospital	admission	
	
Simplified PESI (Pulmonary Embolism Severity Index)
Predicts 30-day outcome of patients with PE, with fewer criteria than the original PESI.
Age >80 years No Yes 
History of cancer No Yes 
History of chronic cardiopulmonary 
disease No Yes 
Heart rate ≥ 110 No Yes 
Systolic BP < 100 mm Hg No Yes 
O2 saturation < 90% No Yes 
Low Risk
1.1% risk of death in the “low” risk group (0 points), with 1.5% having recurrent thromboembolism or 
non-fatal bleeding.
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